Evidence map›Paper›PMID 37095352›Full record

ArticleMolecular psychiatry2023

Characterization of the extracellular free water signal in schizophrenia using multi-site diffusion MRI harmonization.

Suheyla Cetin-Karayumak, Amanda E Lyall, Maria A Di Biase, Johanna Seitz-Holland, Fan Zhang, Sinead Kelly, Doron Elad, Godfrey Pearlson, Carol A Tamminga, John A Sweeney and 16 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Elevated Extracellular Free Water in the Brain Predicts Clinical Improvement in First-Episode Psychosis.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 15 institutions in 7 countries.

Suheyla Cetin-Karayumak *Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. skarayumak@bwh.harvard.edu.ORCID 0000-0002-3315-5821
Amanda E Lyall *Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-8049-516X
Maria A Di BiaseDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Johanna Seitz-HollandDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-1815-2681
Fan ZhangDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-5032-6039
Sinead KellyDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Doron EladRuth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Godfrey PearlsonDepartment of Psychiatry, Yale University, New Haven, CT, USA.
Carol A TammingaDepartment of Psychiatry, UT Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-6366-5697
John A SweeneyDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, USA.ORCID 0000-0003-1752-2828
Brett A ClementzDepartments of Psychology and Neuroscience, Bio-Imaging Research Center, University of Georgia, Athens, GA, USA.
David SchretlenDepartment of Psychiatry and Behavioral Sciences, Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD, USA.ORCID 0000-0003-3992-5601
Katharina StegmayerUniversity Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
Sebastian WaltherUniversity Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.ORCID 0000-0003-4026-3561
Jungsun LeeDepartment of Psychiatry, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Tim CrowDepartment of Psychiatry, SANE POWIC, Warneford Hospital, University of Oxford, Oxford, UK.ORCID 0000-0002-5482-6655
Anthony JamesDepartment of Psychiatry, SANE POWIC, Warneford Hospital, University of Oxford, Oxford, UK.ORCID 0000-0002-2742-8328
Aristotle VoineskosCentre for Addiction and Mental Health, Toronto, ON, Canada.ORCID 0000-0003-0156-0395
Robert W BuchananMaryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, USA.
Philip R SzeszkoDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Anil K MalhotraThe Feinstein Institutes for Medical Research and Zucker Hillside Hospital, Glen Oaks, NY, USA.
Matcheri KeshavanDepartment of Psychiatry, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-5945-888X
Martha E ShentonDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Yogesh RathiDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Ofer PasternakDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-7078-6446
Marek KubickiDepartment of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-3989-8212
Brigham and Women's Hospital · USUniversity of Bern · CHWarneford Hospital · GBBeth Israel Deaconess Medical Center · USCentre for Addiction and Mental Health · CAJames J. Peters VA Medical Center · USJohns Hopkins University · USSouthwestern Medical Center · USTechnion – Israel Institute of Technology · ILUlsan College · KRUniversity of Cincinnati · USUniversity of Georgia · USUniversity of Maryland, Baltimore · USYale University · USZucker Hillside Hospital · US

Funding

Psychosis Risk Evaluation, Data Integration and Computational Technologies (PREDICT): Data Processing, Analysis, and Coordination CenterU24MH124629 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI Rene S. Kahn, Martha E. Shenton · 2020 to 2026
$32.6M
Striatal D2/D3 Dopamine receptor availability in first episode schizophreniaP50MH080173 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI KANE, JOHN M · 2008 to 2012
$10.4M
Trials Operation Unit (OPERATIONS CORE)P30MH090590 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORNBLATT, BARBARA A. · 2010 to 2014
$7.9M
Human Connectome Project for Early PsychosisU01MH109977 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI BREIER, ALAN, SHENTON, MARTHA E. · 2016 to 2020
$5.5M
Harmonizing multi-site diffusion MRI acquisitions for neuroscientific analysis across ages and brain disordersR01MH119222 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI O'DONNELL, LAUREN JEAN, RATHI, YOGESH · 2019 to 2023
$4.0M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077862 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI SWEENEY, JOHN A · 2007 to 2010
$3.1M
Diffusion Imaging Biomarkers for Risk, Onset and Outcome in SchizophreniaR01MH102377 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI KUBICKI, MAREK · 2014 to 2018
$2.8M
Next Generation Diffusion MRI Biomarkers for Prodromal SchizophreniaR01MH108574 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI PASTERNAK, OFER · 2016 to 2020
$2.2M
Evaluating the Impact of Restrictive Eating Disorders on White Matter DevelopmentR01MH130781 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI Marek Kubicki · 2022 to 2026
$2.1M
Diffusion Tensor Imaging in First-Episode SchizophreniaR01MH076995 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI SZESZKO, PHILIP R · 2007 to 2010
$1.2M
Mentoring and Neuroimaging Research on White Matter Pathology in SchizophreniaK24MH110807 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI KUBICKI, MAREK · 2017 to 2021
$945k
Neuroimaging of the Biological Correlates of Early Psychosis: A MR-PET StudyK01MH115247 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI LYALL, AMANDA ELLIS · 2018 to 2022
$889k
Medical Research Council G0500092NIMH NIH HHS K01 MH115247NIMH NIH HHS K24 MH110807NIMH NIH HHS P30 MH090590NIMH NIH HHS P50 MH080173NIMH NIH HHS R01 MH076995NIMH NIH HHS R01 MH077862NIMH NIH HHS R01 MH102377NIMH NIH HHS R01 MH108574NIMH NIH HHS R01 MH119222NIMH NIH HHS R01 MH130781NIMH NIH HHS R03 MH110745NIMH NIH HHS U01 MH109977NIMH NIH HHS U24 MH124629
6 · The paper itself

Abstract

Studies applying Free Water Imaging have consistently reported significant global increases in extracellular free water (FW) in populations of individuals with early psychosis. However, these published studies focused on homogenous clinical participant groups (e.g., only first episode or chronic), thereby limiting our understanding of the time course of free water elevations across illness stages. Moreover, the relationship between FW and duration of illness has yet to be directly tested. Leveraging our multi-site diffusion magnetic resonance imaging(dMRI) harmonization approach, we analyzed dMRI scans collected by 12 international sites from 441 healthy controls and 434 individuals diagnosed with schizophrenia-spectrum disorders at different illness stages and ages (15-58 years). We characterized the pattern of age-related FW changes by assessing whole brain white matter in individuals with schizophrenia and healthy controls. In individuals with schizophrenia, average whole brain FW was higher than in controls across all ages, with the greatest FW values observed from 15 to 23 years (effect size range = [0.70-0.87]). Following this peak, FW exhibited a monotonic decrease until reaching a minima at the age of 39 years. After 39 years, an attenuated monotonic increase in FW was observed, but with markedly smaller effect sizes when compared to younger patients (effect size range = [0.32-0.43]). Importantly, FW was found to be negatively associated with duration of illness in schizophrenia (p = 0.006), independent of the effects of other clinical and demographic data. In summary, our study finds in a large, age-diverse sample that participants with schizophrenia with a shorter duration of illness showed higher FW values compared to participants with more prolonged illness. Our findings provide further evidence that elevations in the FW are present in individuals with schizophrenia, with the greatest differences in the FW being observed in those at the early stages of the disorder, which might suggest acute extracellular processes.

Indexed as

BrainDiffusion Magnetic Resonance ImagingSchizophreniaWhite MatterAdolescentAdultFemaleHumansMaleMiddle AgedPsychotic DisordersWaterYoung AdultWater

Identifiers

PMID37095352
PMCPMC11146151
OpenAlexW4366827617

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.